Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in India: GlobalData Read more
Dr Reddy’s Laboratories among top 15 biotech and pharma employers in Science Magazine Survey Read more
Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma Read more